Cutaneous lesions that occur during treatment with BRAF inhibitors lack of a commonly shared histopathological classifi- cation, thus affecting the true incidence of skin cancer, which varies in the reported studies also considering the same drug.
Squamoproliferative skin lesion during braf inhibitors:one size does not fit all / M. Mandalà; A. Gianatti; D. Massi. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - STAMPA. - (2013), pp. ---.
Squamoproliferative skin lesion during braf inhibitors:one size does not fit all.
MASSI, DANIELA
2013
Abstract
Cutaneous lesions that occur during treatment with BRAF inhibitors lack of a commonly shared histopathological classifi- cation, thus affecting the true incidence of skin cancer, which varies in the reported studies also considering the same drug.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
